Henry Schein key statistics and ratios
In fiscal 2025, Henry Schein had return on equity of 12.0%, an operating margin of 5.0%, debt equal to 95.7% of equity and a current ratio of 1.38. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 29.3% | 28.8% | 28.3% | 28.0% | 27.8% | 28.1% | 28.3% | 27.9% | 22.0% | 22.0% | 31.0% | 27.8% | 29.6% | 30.3% | 31.3% | 31.7% | 31.1% | 31.6% |
| Operating margin | 7.1% | 6.9% | 6.8% | 6.9% | 7.1% | 6.9% | 6.9% | 6.7% | 5.4% | 4.5% | 7.2% | 5.3% | 6.9% | 5.9% | 5.0% | 4.9% | 5.0% | 5.2% |
| Net margin | 4.8% | 4.3% | 4.3% | 4.3% | 4.5% | 4.5% | 4.5% | 4.4% | 3.3% | 4.1% | 7.0% | 4.0% | 5.1% | 4.3% | 3.4% | 3.1% | 3.0% | 3.1% |
| Free-cash-flow margin | 5.3% | 4.7% | 6.0% | 4.0% | 6.3% | 4.9% | 5.1% | 4.9% | 3.9% | 4.6% | 5.8% | 5.4% | 5.1% | 4.0% | 2.9% | 5.5% | 4.3% | 4.1% |
| Return on equity | 14.4% | 14.2% | 15.2% | 15.4% | 16.0% | 16.6% | 16.8% | 17.9% | 14.5% | 18.6% | 23.3% | 12.7% | 18.6% | 15.7% | 11.7% | 11.1% | 12.0% | 13.1% |
| Return on assets | 8.1% | 7.8% | 7.9% | 7.7% | 7.9% | 7.9% | 7.6% | 7.6% | 5.5% | 6.5% | 8.9% | 5.4% | 7.8% | 6.3% | 4.3% | 3.8% | 3.7% | 3.7% |
| Asset turnover | 1.70 | 1.80 | 1.84 | 1.77 | 1.74 | 1.76 | 1.68 | 1.73 | 1.70 | 1.61 | 1.28 | 1.36 | 1.53 | 1.48 | 1.29 | 1.22 | 1.23 | 1.21 |
| Current ratio | 2.05 | 1.86 | 1.79 | 1.84 | 1.83 | 1.64 | 1.50 | 1.44 | 1.44 | 1.30 | 1.58 | 1.66 | 1.67 | 1.79 | 1.67 | 1.42 | 1.38 | 1.33 |
| Debt to equity | 12.4% | 18.3% | 18.1% | 20.4% | 17.4% | 26.0% | 28.1% | 43.6% | 59.3% | 65.5% | 25.2% | 20.9% | 25.5% | 33.3% | 64.3% | 74.7% | 95.7% | 111.6% |
| Interest cover (operating income ÷ interest) | 19.9x | 15.5x | 19.2x | 20.0x | 24.6x | 29.7x | 28.2x | 24.2x | 13.1x | 7.9x | 14.1x | 13.0x | 31.6x | 21.3x | 7.1x | 4.7x | 4.4x | 4.3x |
| Effective tax rate | 28.2% | 31.9% | 31.7% | 31.1% | 28.7% | 30.4% | 29.3% | 28.8% | 49.1% | 20.0% | 23.4% | 19.0% | 23.8% | 23.6% | 22.1% | 25.0% | 23.6% | 24.3% |
| SG&A as % of revenue | 22.2% | 21.8% | 21.5% | 21.0% | 20.7% | 21.2% | 21.1% | 20.8% | 16.6% | 16.8% | 23.6% | 20.6% | 21.2% | 21.9% | 24.0% | 23.9% | 23.4% | 23.8% |
| Capital spending as % of revenue | 0.8% | 0.5% | 0.5% | 0.6% | 0.6% | 0.8% | 0.7% | 0.6% | 0.5% | 0.5% | 0.8% | 0.5% | 0.6% | 0.8% | 1.2% | 1.2% | 1.1% | 0.9% |
| Free cash flow ÷ net income | 111.3% | 109.4% | 138.6% | 92.0% | 139.9% | 109.5% | 113.5% | 112.9% | 118.9% | 114.5% | 83.2% | 136.1% | 100.0% | 94.1% | 84.9% | 179.5% | 144.0% | 132.8% |
| Dividends and buybacks ÷ free cash flow | 0.0% | 16.2% | 39.3% | 84.0% | 49.7% | 58.8% | 55.1% | 96.1% | 93.1% | 32.6% | 90.9% | 13.5% | 63.5% | 95.8% | 70.8% | 55.0% | 148.3% | 116.3% |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 31.1% | 31.6% | 31.4% | 30.7% | 30.9% | 31.8% | 31.8% | 31.8% |
| Operating margin | 4.9% | 5.5% | 4.7% | 4.9% | 4.7% | 5.4% | 4.9% | 5.6% |
| Net margin | 2.9% | 3.5% | 2.7% | 3.0% | 2.9% | 3.2% | 2.7% | 3.4% |
| Free-cash-flow margin | 5.3% | 0.2% | 2.7% | 4.2% | 9.8% | −3.6% | 6.1% | 3.8% |
| Current ratio | 1.42 | 1.38 | 1.41 | 1.40 | 1.38 | 1.36 | 1.32 | 1.33 |
| Debt to equity | 73.1% | 85.6% | 86.8% | 91.2% | 94.7% | 103.3% | 105.3% | 107.1% |
| SG&A as % of revenue | 23.1% | 23.3% | 24.0% | 22.8% | 23.5% | 24.0% | 24.0% | 23.6% |
Financial health
- Short-term assets cover short-term liabilities $4.8bn of assets due within a year against $3.6bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $4.8bn short-term assets against $3.2bn of longer-dated liabilities.
- More cash than debt $184m of cash against $3.4bn of debt.
- Debt below 40% of shareholders' equity Debt is 107% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 22% to 107% over five years.
- A year's operating cash flow covers at least 20% of debt $687m of operating cash flow against $3.4bn of debt.
- Operating profit covers interest at least five times over Operating income of $709m against $163m of interest.
Moat
Moderate moat
How hard Henry Schein's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 10 / 20
Cash operating profit has been a median 8.4% of total assets over 10 years.
- Pricing power 10 / 20
Gross margin has been a median 29.6%, moving by 3.1 percentage points (standard deviation) across 10 years.
- Durability 10 / 20
Operating margin has been a median 5.2%; its worst year was 4.0%.
- Cash conversion 12 / 20
Free cash flow was positive in 10 of 10 years, at a median 4.3% of revenue.
- Discipline 20 / 20
The diluted share count fell 19.2% over five years; stock-based pay has been a median 0.3% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (62 before it).
Compare with peers
- 111, Inc. statistics
- Cencora statistics
- McKesson statistics
- Cosmos Health Inc. statistics
- Cellyan Biotechnology Co., Ltd statistics
Head to head: HSIC vs YICOR vs HSICHSIC vs MCKCOSM vs HSIC
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies